Literature DB >> 20373270

[Implementation of "aut idem" before and after introduction of rebate contracts].

F Hoffmann1, R Windt, G Glaeske.   

Abstract

OBJECTIVE: Due to the aut-idem regulation pharmacies are obligated to substitute medications within the statutory health insurance system to low-priced generics or to dispense the prescribed drug (if only a compound is prescribed low-priced generics have to be dispensed). Since April 1st, 2007 pharmacies have to replace non-rebated by rebated drugs. We aimed to investigate if the prescribing of compounds and substitutions in pharmacies has changed after the introduction of rebate contracts.
METHODS: We used claims data of the Gmünder ErsatzKasse (GEK) and drew 3 random samples of 1,000 relevant prescriptions each in October 2006, 2007 and 2008. After that, all relevant original prescriptions were screened.
RESULTS: Between October in 2006, 2007 and 2008, we observed no change in prescribing compounds only (6.0 %; 7.7 %; 6.8 %; p = 0.47). Prescribing compounds was associated with, e. g. dentists, small packages (N1 vs. N3) and antiinfectives. We found a considerable increase in medications that were substituted in pharmacies (2006: 11.3 %; 2007: 29.1 %; 2008: 39.2 %; p <0.0001).
CONCLUSION: Only through the introduction of rebate contracts an increasing amount of substituted medications took place in pharmacies. Before that, the aut-idem regulation had no considerable regulatory effect.

Entities:  

Mesh:

Year:  2010        PMID: 20373270     DOI: 10.1055/s-0030-1251926

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

Review 1.  Pharmaceutical policies: effects of financial incentives for prescribers.

Authors:  Arash Rashidian; Amir-Houshang Omidvari; Yasaman Vali; Heidrun Sturm; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2015-08-04

2.  Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons.

Authors:  Gabriele Gradl; Eva-Maria Krieg; Martin Schulz
Journal:  Pharm Pract (Granada)       Date:  2016-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.